DEDICATED TO EXCELLENCE IN CUSTOM SYNTHESIS

Alchem can be a value-creating partner for both established and start-up pharmaceutical companies, as well as government programs.  Our current partners and collaborators include:

  • National Cancer Institute (NCI) / National Institutes of Health (NIH)

  • National Institute of Standards and Technology (NIST)

  • U.S. Army Medical Research Acquisition Activity (USAMRAA) / Department of Defense (DoD)

  • U.S. Department of Agriculture (USDA)

  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (ICP)

  • Atossa Genetics Inc. (NASDAQ: ATOS)

  • Andarix Pharmaceuticals, Inc.

  • Bio Protectant Technologies Inc.

  • Brickell Biotech, Inc.

  • Cato Research

  • Cerenis Therapeutics Holding SA (CEREN.PA)

  • Discovery Cure Institute, Inc. (DCI)

  • Eurofins

  • FLUCEL LLC

  • IIT Research Institute (IITRI)

  • Medical CBRN Defense Consortium (MCDC)

  • MLM Biologics, Inc.

  • Molecular Forecaster

  • Mountain Valley MD Holdings Inc. (MVMD.CN)

  • MRIGlobal

  • Nanopharmaceutics, Inc.

  • Nelson Laboratories

  • Northwell Health

  • OPTOSURGICAL, LLC

  • Oragenics, Inc. (NYSE: OGEN)

  • Pace Analytical Labs

  • Praxis Bioresearch, LLC

  • Southern Research

  • ThermoFisher Scientific Inc. (NYSE: TMO)

  • TRACON Pharmaceuticals, Inc. (Nasdaq: TCON)

  • Univar Solutions Inc. (NYSE: UNVR)

  • UF Innovate / Sid Martin Biotech